High level of correlation of human papillomavirus-16 DNA viral load estimates generated by three real-time PCR assays applied on genital specimens

Cancer Epidemiology Biomarkers and Prevention

Volumn 14, Issue 9, 2005, Pages 2200-2207

  Fontaine, Julie ^a,b   Gravitt, Patti ^e   Duh, Lee Min ^e   Lefevre, Jonas ^a   Pourreaux, Karina ^d   Hankins, Catherine ^c,d,f   Coutlée, François ^a,b,c,f,g   Conners, Janet ^f   Grimshaw, Rob ^f   Haase, David ^f   Johnston, Lynn ^f   Schlech, Wally ^f   Yuzicappi Fayant, Arlo ^f   Landis, Stephen ^f   Smaill, Fiona ^f   Austin, Tom ^f   Hammerberg, Ole ^f   Ralph, Ted ^f   Falutz, Julian ^f   Ferenczy, Alex ^f   Klein, Marina ^f   Labrecque, Louise ^f   Lapointe, Normand ^f   Lalonde, Richard ^f   Macleod, John ^f   Noël, Grégoire ^f   Perron, Chantal ^f   Routy, Jean Pierre ^f   Toma, Emil ^f   Touchie, Claire ^f   Victor, Garry ^f   Coté, Louise ^f   Senay, Hélène ^f   Trottier, Sylvie ^f   Williams, Kurt ^f   Piché, Alain ^f   Sandre, Roger ^f   Binder, Louise ^f   Keystone, Donna ^f   Phillips, Anne ^f   Rachlis, Anita ^f   Salit, Irving ^f   Wagner, Cheryl ^f   Walmsley, Sharon ^f   Braitstein, Paula ^f   Burdge, David ^f   Harris, Marianne ^f   Money, Deborah ^f   Montaner, Julio ^f   more..

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d INSTITUT NATIONAL DE SANTÉ PUBLIQUE DU QUÉBEC   (Canada)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f NONE

^g NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CORRELATION COEFFICIENT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; MAJOR CLINICAL STUDY; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TAMPON; UTERINE CERVIX; UTERINE CERVIX CYTOLOGY; VIRUS LOAD;

EID: 27744554200     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0055     Document Type: Article

References (60)

1. Jamieson DJ, Duerr A, Burk R, et al. Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol 2002;186:21-7.
2. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA 2000;283:1031-7.
3. Moscicki AB, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls-impact of infection with human immunodeficiency virus. Arch Pediatr Adolesc Med 2000;154:127-34.
4. de Sanjose S, Palefsky J. Cervical and anal HPV infections in HIV positive women and men. Virus Res 2002;89:201-11.
5. Bosch FX, Lorincz A, Munoz N, Meijer CJLM, Shah KV. The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 2002;55:244-65.
6. Clifford GM, Smith JS, Aguado T, Franceschi S. Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis. Br J Cancer 2003;89:101-5.
7. Ferenczy A, Franco EL. Persistent human papillomavirus infection and cervical neoplasia. Lancet Oncol 2002;3:11-6.
8. Ylitalo N, Sorensen P, Josefsson AM, et al. Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2194-8.
9. Swan DC, Tucker RA, Tortolero-Luna G, et al. Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type. J Clin Microbiol 1999;37:1030-4.
10. Josefsson AM, Magnusson PKE, Ylitalo N, et al. Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet 2000;355:2189-93.
11. Womack SD, Chirenje ZM, Gaffikin L, et al. HPV-based cervical cancer screening in a population at high risk for HIV infection. Int J Cancer 2000;85:206-10.
12. Schlecht NF, Trevisan A, Duarte-Franco E, et al. Viral load as a predictor of the risk of cervical intraepithelial neoplasia. Int J Cancer 2003;103:519-24.
13. Lefevre J, Hankins C, Pourreaux K, Coutlée F; The Canadian Women's HIV Study Group. Human papillomavirus type 16 viral load is increased in HIV-seropositive women with high-grade squamous intraepithelial lesions compared to those with normal cytology smears. J Clin Microbiol 2004;42:2212-5.
14. Shah KV, Solomon L, Daniel R, Cohn S, Vlahov D. Comparison of PCR and hybrid capture methods for detection of human papillomavirus in injection drug-using women at high risk of human immunodeficiency virus infection. J Clin Microbiol 1997;35:517-9.
15. Weissenborn SJ, Funke AM, Hellmich M, et al. Oncogenic Human papillomavirus DNA loads in human immunodeficiency virus-positive women with High-grade cervical lesions are strongly elevated. J Clin Microbiol 2003;41:2763-7.
16. Peitsaro P, Johansson B, Syrjanen S. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 2002;40:886-91.
17. van Duin M, Snidjers PJF, Schrijnemakers HFJ, et al. Human papillomavirus 16 load in normal and abnormal cervical scrapes: an indicator of CIN II/III and viral clearance. Int J Cancer 2002;98:590-5.
18. Sherman ME, Wang SS, Wheeler CM, et al. Histopathologic extent of cervical intraepithelial neoplasia 3 lesions in the atypical squamous cells of undetermined significance low-grade squamous intraepithelial lesion triage study: implications for subject safety and lead-time bias. Cancer Epidemiol Biomarkers Prev 2003;12:1038-44.
19. Sun XW, Ferenczy A, Johnson D, et al. Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol 1995;173:1432-7.
20. Clavel C, Masure M, Putaud I, et al. Hybrid capture II, a new sensitive test for human papillomavirus detection. Comparison with hybrid capture I and PCR results in cervical lesions. J Clin Pathol 1998;51:737-40.
21. Clavel C, Bory JP, Rihet S, et al. Comparative analysis of human papillomavirus detection by hybrid capture assay and routine cytologic screening to detect high-grade cervical lesions. Int J Cancer 1998;75:525-8.
22. Nindl I, Lorincz A, Mielzynska I, et al. Human papillomavirus detection in cervical intraepithelial neoplasia by the second generation hybrid capture microplate test, comparing two different cervical specimen collection methods. Clin Diagn Virol 1998;10:49-56.
23. Sigurdsson K, Arnadottir T, Snorradottir M, Benediktsdottir K, Saemundsson H. Human papillomavirus (HPV) in an Icelandic population: correlation of HPV DNA to cytologic and histopathologic lesions and evaluation of treatment strategies. Int J Gynecol Cancer 1996;6:175-82.
24. Cox JT, Lorincz AT, Schiffman MH, Sherman ME, Cullen A, Kurman RJ. Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 1995;172:946-54.
25. Hall S, Lorincz AT, Shah F, et al. Human papillomavirus DNA detection in cervical specimens by hybrid capture: correlation with cytologic and histologic diagnoses of squamous intraepithelial lesions of the cervix. Gynecol Oncol 1996;62:353-9.
26. Lorincz AT, Castle PE, Sherman ME, et al. Viral load of human papillomavirus and risk of CIN3 or cervical cancer. Lancet 2002;360:228-9.
27. Sherman ME, Schiffman M, Cox JT. Effects of age and human papilloma viral load on colposcopy triage: data from the randomized atypical squamous cells of undetermined significance/low grade squamous intraepithelial lesion triage study (ALTS). J Natl Cancer Inst 2002;94:102-7.
28. Fontaine J, Hankins C, Mayrand MH, et al. High levels of episomal and integrated HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV. AIDS. 2005;19:785-94.
29. Gravitt PE, Burk RD, Lorincz A, et al. A comparison between real-time polymerase chain reaction and hybrid capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol Biomarkers Prev 2003;12:477-84.
30. Prétet JL, Dalstein V, Monnier-Benoit S, Delpeut S, Mougin C. High risk HPV load estimated by hybrid capture II correlates with HPV16 load measured by real-time PCR in cervical smears of HPV-16 infected women. J Clin Virol 2004;31:140-7.
31. Lefevre J, Hankins C, Pourreaux K, Voyer H, Coutlée F; The Canadian Women's HIV Study Group. Real-time PCR assays using internal controls for quantitation of HPV-16 and β-globin DNA in cervicovaginal lavages. J Virol Methods 2003;144:135-44.
32. Lefevre J, Hankins C, Pourreaux K, Coutlée F; The Canadian Women's HIV study Group. Prevalence of selective inhibition of HPV-16 DNA amplification in cervicovaginal lavages. J Med Virol 2004;72:132-7.
33. Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R, Shah KV. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J Virol Methods 2003;112:23-33.
34. Josefsson A, Livak K, Gyllensten U. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay. J Clin Microbiol 1999;37:490-6.
35. Swan DC, Tucker RA, Holloway BP, Icenogle JP. A sensitive, type-specific, fluorogenic probe assay for detection of human papillomavirus DNA. J Clin Microbiol 1997;35:886-91.
36. Wang-Johanning F, Lu DW, Wang Y, Johnson MR, Johanning GL. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis. Cancer 2002;94:2199-210.
37. Moberg M, Gustavsson I, Gyllensten U. Real-time PCR-based system for simultaneous quantification of human papillomavirus types associated with high risk of cervical cancer. J Clin Microbiol 2003;41:3221-8.
38. Beskow AH, Gyllensten UB. Host genetic control of HPV 16 titer in carcinoma in situ of the cervix uteri. Int J Cancer 2002;101:526-31.
39. Hankins C, Coutlee F, Lapointe N, et al. Prevalence of risk factors associated with human papillomavirus infection in women living with HIV. Can Med Assoc J 1999;160:185-91.
40. Coutlée F, Hankins C, Lapointe N, et al. Comparison between vaginal tampon and cervicovaginal lavage specimens collection for detection of human papillomavirus DNA by the polymerase chain reaction. J Med Virol 1997;51:42-7.
41. Hankins C, Lapointe N, Walmsley S; The Canadian Women's HIV Study Group. Participation in clinical trials among women living with HIV in Canada. Can Med Assoc J 1998;159:1359-65.
42. Hildesheim A, Schiffman MH, Gravitt PE, et al. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis 1994;169:235-40.
43. 1991 Bethesda Workshop. The 1991 Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda Workshop. JAMA 1992;267:1892.
44. Tarkowski TA, Rajeevan MS, Lee DR, Unger ER. Improved detection of viral RNA isolated from liquid-based cytology samples. Mol Diagn 2001;6:125-30.
45. Yuan CC, Miley W, Waters D. A quantification of human cells using an ERV-3 real time PCR assay. J Virol Methods 2001;91:109-17.
46. Villa LL, Sichero L, Rahal P, et al. Molecular variants of human papillomavirus types 16 and 18 preferentially associated with cervical neoplasia. J Gen Virol 2000;81 Pt 12:2959-68.
47. van Duin M, Snijders PJF, Vossen MTM, et al. Analysis of human papillomavirus type 16 E6 variants in relation to p53 codon 72 polymorphism genotypes in cervical carcinogenesis. J Gen Virol 2000;81:317-25.
48. Yamada T, Manos MM, Peto J, et al. Human papillomavirus type 16 sequence variation in cervical cancers-a worldwide perspective. J Virol 1997;71:2463-72.
49. Gravitt PE, Peyton C, Wheeler C, Apple R, Higuchi R, Shah KV. Reproducibility of HPV 16 and HPV 18 viral load quantitation using TaqMan real-time PCR assays. J Virol Methods 2003;112:23-33.
50. Nagao S, Yoshinouchi M, Miyagi Y, et al. Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR. J Clin Microbiol 2002;40:863-7.
51. Schiffman MH, Kiviat NB, Burk RD, et al. Accuracy and interlaboratory reliability of human papillomavirus DNA testing by hybrid capture. J Clin Microbiol 1995;33:545-50.
52. Casas L, Galvan SC, Ordonez RM, Lopez N, Guido M, Berumen J. Asian-American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. Int J Cancer 1900;83:449-55.
53. Berumen J, Ordonez RM, Lazcano E, et al. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J Natl Cancer Inst 2001;93:1325-30.
54. Giannoudis A, Herrington CS. Human papillomavirus variants and squamous neoplasia of the cervix. J Pathol 2001;193:295-302.
55. de Boer MA, Peters LA, Aziz MF, et al. Human papillomavirus type 16 E6; E7; and L1 variants in cervical cancer in Indonesia, Suriname, and the Netherlands. Gynecol Oncol 2004;94:488-94.
56. Wheeler CM, Yamada T, Hildesheim A, Jenison SA. Human papillomavirus type 16 sequence variants-identification by E6 and L1 lineage-specific hybridization. J Clin Microbiol 1997;35:11-9.
57. Yamada T, Wheeler CM, Halpern AL, Stewart AC, Hildesheim A, Jenison SA. Human papillomavirus type 16 variant lineages in United States populations characterized by nucleotide sequence analysis of the E6; L2; and L1 coding segments. J Virol 1995;69:7743-53.
58. Buonaguro FM, Tornesello ML, Salatiello I, et al. The Uganda study on HPV variants and genital cancers. J Clin Virol 2000;19:31-41.
59. Icenogle J, Sathya P, Miller DL, Tucker RA, Rawls WE. Nucleotide and amino acid sequence variation in the L1 and E7 open reading frames of human papillomavirus type 6 and type 16. Virology 1991;184:101-7.
60. Chan S-Y, Ho L, Ong C-K, et al. Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol 1992;66:2057-66.